Marina N. Fleeton - Concepedia

Author

Marina N. Fleeton

Also Known As

M N Fleeton, M. Fleeton, MARINA FLEETON, Marina FLEETON, Marina Fleeton, Marina N Fleeton, Marina N. Fleeton, Marina N. Fleeton

Publications

1.4K

Citations

H-Index

Concepts

All Affiliations

Trinity College Dublin Karolinska Institutet Swedish Institute University College Dublin Vanderbilt University

About

Marina N. Fleeton is an author at Trinity College Dublin specializing in medicine, immunology, and vaccination.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	636
2	Immunology	8	8	636
3	Allergy	2	2	132
4	Pathology	2	2	79
5	Host-pathogen Interactions	1	1	64

Marina N. Fleeton

Publications

1.2K

Citations

H-Index

Page 1

	Year	Citations
Enhancing immune responses using suicidal DNA vaccines Peter Berglund, Cristian Smerdou, Marina N. Fleeton, Nature Biotechnology VaccinationMedicineImmunologyTherapeutic VaccineVaccine Design	1998	234
Discovery of frameshifting in Alphavirus 6K resolves a 20-year enigma Andrew E. Firth, Betty Chung, Marina N. Fleeton, Virology Journal	2008	178
Self‐Replicative RNA Vaccines Elicit Protection against Influenza A Virus, Respiratory Syncytial Virus, and a Tickborne Encephalitis Virus Marina N. Fleeton, Margaret Chen, Peter Berglund, The Journal of Infectious Diseases	2001	153
Peyer's Patch Dendritic Cells Process Viral Antigen from Apoptotic Epithelial Cells in the Intestine of Reovirus-infected Mice Marina N. Fleeton, Nikhat Contractor, Francisco León, The Journal of Experimental Medicine	2004	143
Immunization with recombinant Semliki Forest virus induces protection against influenza challenge in mice Peter Berglund, Marina N. Fleeton, Cristian Smerdou, Vaccine VaccinationVaccine DevelopmentImmunologyInfluenza ChallengeVirology	1999	116
Recombinant Semliki Forest virus particles expressing louping ill virus antigens induce a better protective response than plasmid-based DNA vaccines or an inactivated whole particle vaccine Marina N. Fleeton, B. J. Sheahan, Gregory J. Atkins, Journal of General Virology VaccinationCross-protectionIll VirusAllergyVaccine Development	2000	68
Recombinant Semliki Forest virus particles encoding the prME or NS1 proteins of louping ill virus protect mice from lethal challenge. Marina N. Fleeton, B. J. Sheahan, Ernest A. Gould, Journal of General Virology Viral PathogenesisImmunologyNs1 ProteinsImmunotherapyVaccine Target	1999	64
Inhibition of angiogenesis by a Semliki Forest virus vector expressing VEGFR-2 reduces tumour growth and metastasis in mice Jeri‐Anne Lyons, B. J. Sheahan, Sareen E. Galbraith, Gene Therapy Tumor BiologyAngiogenesisVegfr-2 ReducesImmunologyCancer Growth	2006	47
Regression of mouse tumours and inhibition of metastases following administration of a Semliki Forest virus vector with enhanced expression of IL-12 C.P. Chikkanna-Gowda, B. J. Sheahan, Marina N. Fleeton, Gene Therapy ImmunologyAntiviral ResponsePathologyEnhanced ExpressionMouse Tumours	2005	44
MyD88 Expression Is Required for Efficient Cross-Presentation of Viral Antigens from Infected Cells Margaret Chen, Christina Barnfield, Tanja I. Näslund, Journal of Virology	2005	41

Page 1